Eco Animal Regulatory News (EAH)

14 October 2024

ECO Animal Health Group plc

("ECO" or the "Company")

EBT Share Purchase

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces it has been notified that the trustees of the ECO Animal Health Group EBT (the "EBT") have, on 11 October 2024 purchased 50,000 ordinary shares of 10p each in the Company ("Ordinary Shares") at a price of 72 pence per Ordinary Share.

These Ordinary Shares are to be held in the EBT and are intended to be used to satisfy the future vesting of share options granted to employees of the Company. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company. The purchase of Ordinary Shares by the EBT has been funded by a gift provided by the Company from its existing cash resources.

Following this transaction, a total of 50,000 Ordinary Shares are held by the EBT, representing approximately 0.07 per cent. of the Company's total voting rights.

-Ends-

For further information please contact:

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

 Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

 Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com